Sanofi India quarterly results and financials

Sanofi India (SANOFI)₹3,329+0.83%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Sanofi India reported sales of ₹439 Cr, up 7.9% from Jun 2025, and net profit of ₹84.01 Cr, up 19.9% year on year. For the year to Dec 2025, sales were ₹1,842 Cr and net profit ₹327 Cr.

Sales (Jun 2026): ₹439 Cr
Net profit (Jun 2026): ₹84.01 Cr
Sales (FY Dec 2025): ₹1,842 Cr
Net profit (FY Dec 2025): ₹327 Cr
EPS (Jun 2026): ₹36.40
Borrowings (Dec 2025): ₹17.98 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Sanofi India quarterly results

₹ crore unless stated; each column is a quarter.

Sanofi India Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	492	470	513	465	526	516	537	407	477	421	474	439
Expenses	378	371	375	349	405	399	365	312	342	331	331	323
Operating Profit	114	99.96	137	116	120	118	172	94.97	134	89.92	143	115
OPM %	23.0%	21.0%	26.9%	24.9%	22.9%	22.9%	31.9%	23.0%	28.0%	21.9%	29.9%	26.0%
Other Income	82.30	77.20	41.15	21.06	2.01	14.03	3.01	9.02	−22.07	3.01	4.01	6.02
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	0.00
Depreciation	9.02	9.03	9.03	9.03	9.02	10.03	10.03	9.03	9.03	10.03	9.03	9.03
Profit before tax	186	167	169	127	113	122	165	93.83	102	82.93	138	112
Tax %	18.0%	18.0%	19.0%	19.0%	27.0%	25.0%	28.0%	26.0%	26.0%	26.0%	26.0%	26.0%
Exceptional items	71.86	67.90	27.97	10.97	0.00	5.99	0.00	0.00	−18.96	0.00	0.00	0.00
Net Profit	152	138	137	103	81.99	91.06	120	70.06	76.06	61.99	103	84.01
EPS (Rs)	66.39	60.02	59.58	45.11	35.85	39.81	52.13	30.29	33.13	26.89	44.77	36.40

Sanofi India profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Sanofi India Profit and loss
	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025	TTM
Sales	2,200	2,375	2,469	2,782	3,080	2,911	2,964	2,778	2,859	2,018	1,842	1,811
Expenses	1,823	1,838	1,928	2,154	2,412	2,194	2,201	2,073	2,055	1,529	1,350	1,328
Operating Profit	376	534	537	625	666	715	762	704	804	490	491	482
OPM %	17.0%	22.9%	21.9%	23.0%	21.9%	25.0%	25.9%	24.9%	28.0%	23.9%	26.9%	26.6%
Other Income	219	66.22	79.23	88.21	33.10	45.14	566	205	83.21	79.19	−8.03	−9.03
Interest	0.00	2.01	1.01	1.01	0.00	2.01	2.01	2.01	2.01	2.01	2.01	1.01
Depreciation	113	119	102	103	100	82.18	67.23	42.11	40.12	37.12	37.11	37.12
Profit before tax	480	479	514	609	600	677	1,255	863	845	530	445	434
Tax %	33.0%	37.0%	37.0%	38.0%	31.0%	29.0%	25.0%	28.0%	29.0%	22.0%	27.0%	—
Exceptional items	54.94	0.00	−0.99	−0.99	−37.94	−30.94	362	94.78	12.98	−28.93	−19.97	−18.96
Net Profit	322	304	326	381	414	478	945	621	604	414	327	325
EPS (Rs)	140.14	132.75	142.22	166.07	180.62	208.32	411.55	270.62	262.91	180.27	142.38	141.19
Dividend payout %	46.1%	51.0%	50.1%	51.0%	194.1%	176.1%	119.0%	211.0%	64.0%	65.0%	87.0%	—

Sanofi India balance sheet

₹ crore, at each year end.

Sanofi India Balance sheet
	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Equity Capital	23.07	23.09	23.08	23.08	23.08	23.06	23.09	23.06	23.07	23.07	23.07	23.09
Reserves	1,461	1,602	1,858	2,000	2,191	2,415	2,094	2,201	1,251	991	837	725
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	22.99	24.99	23.97	18.98	18.97	17.98
Other Liabilities	742	780	657	750	767	802	776	807	770	679	731	487
Total Liabilities	2,226	2,405	2,538	2,774	2,981	3,240	2,915	3,055	2,068	1,712	1,610	1,253
Fixed Assets	650	880	818	770	735	500	465	335	307	316	312	305
CWIP	210	21.98	33.94	29.94	20.96	16.98	9.99	12.99	23.97	15.97	17.96	11.99
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.01	0.00	0.00
Other Assets	1,366	1,503	1,686	1,973	2,225	2,723	2,440	2,707	1,738	1,378	1,279	937
Inventories	479	479	493	417	484	470	368	392	408	665	500	312
Trade receivables	115	144	145	194	158	224	148	143	129	132	229	177
Cash & equivalents	468	571	560	728	830	1,127	1,206	1,545	1,015	404	294	274
Total Assets	2,226	2,405	2,538	2,774	2,981	3,240	2,915	3,055	2,068	1,712	1,610	1,253

Sanofi India cash flow

₹ crore, for each year.

Sanofi India Cash flow
	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from operating activity	266	213	323	436	374	413	612	560	400	231	463	439
Cash from investing activity	60.78	35.91	−154	−78.76	−72.82	65.77	275	629	649	35.90	−178	−10.98
Cash from financing activity	−122	−147	−181	−189	−198	−183	−813	−851	−1,586	−881	−393	−449
Net cash flow	205	102	−12.99	168	104	295	77.95	341	−533	−612	−109	−20.99
Capex	128	159	69.59	57.18	59.42	76.12	41.54	23.09	22.28	34.44	36.52	25.78
Free cash flow	248	185	254	380	318	338	812	576	413	222	427	415
CFO / OP %	114.0%	93.0%	100.9%	118.0%	99.0%	96.0%	112.0%	110.9%	93.9%	59.0%	113.9%	111.0%

Sanofi India ratios

Working-capital days and returns, by year.

Sanofi India Ratios
	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Debtor days	22	25	23	30	22	28	20	19	18	18	43	36
Inventory days	179	173	169	151	154	127	107	110	125	202	186	127
Days payable	122	81	79	119	110	100	93	105	109	89	151	79
Cash conversion cycle	78	115	112	61	65	54	33	22	33	130	77	83
Working capital days	26	9	79	17	18	35	−8	−20	−19	24	17	7
ROCE %	22.0%	26.1%	27.0%	26.1%	29.1%	28.1%	32.0%	35.0%	41.0%	71.0%	49.1%	58.1%

Sanofi India: frequently asked questions

What are the latest quarterly results of Sanofi India?

For the Jun 2026 quarter, Sanofi India reported sales of ₹439 Cr, up 7.9% year on year and net profit of ₹84.01 Cr, up 19.9% year on year. The operating margin was 26.0%.

What is the annual revenue of Sanofi India?

Sanofi India's sales for the year to Dec 2025 were ₹1,842 Cr; over the last twelve months they were ₹1,811 Cr.

What is the net profit of Sanofi India?

Net profit for the year to Dec 2025 was ₹327 Cr, and ₹325 Cr over the last twelve months. Earnings per share over the same trailing period were ₹141.19.

How much debt does Sanofi India have?

Sanofi India reported borrowings of ₹17.98 Cr at Dec 2025, against cash and equivalents of ₹274 Cr.

What is the free cash flow of Sanofi India?

Cash from operations was ₹439 Cr in the year to Dec 2025; after capital spending, free cash flow was ₹415 Cr.

Loading…